Immunotherapy Types
Different varieties of immunotherapy are used to treat cancer, and each type functions differently. Some immunotherapy treatments assist the immune system in slowing or halting the development of cancer cells, whereas others prevent cancer cells from spreading further throughout the body. Immunotherapy treatments can also be combined with other cancer treatments. Doctors determine the appropriate immunotherapy by considering the dose, type of cancer, drug type, treatment schedule, tumor size, tumor location, and cancer progression. Following is a description of various immunotherapy treatment types:
Monoclonal antibodies or inhibitors of checkpoint
Laboratory-produced monoclonal antibodies enhance the immune system by enhancing the function of natural antibodies or serve as antibodies themselves. Various monoclonal antibodies combat malignancy. Targeted therapy is the process by which abnormal proteins enveloping the surface of cancer cells are inhibited from performing their function. However, monoclonal antibodies also enhance the immune system by inhibiting the immune checkpoints. Immune checkpoints are the inherent gates of the immune system that prevent the immune response from attacking normal cells. Nonetheless, cancer cells conceal themselves from the immune system and activate immune checkpoints. The checkpoint inhibitors prevent cancer cells from preventing the activation of immune checkpoints and intensify the immune system’s capacity to kill additional cancer cells. Some checkpoint inhibitors can target specific genetic mutations to treat tumors, and these treatments are known as tumor-agnostic. The following are examples of immune checkpoint inhibitors:
The drug Nivolumab
The drug Duravalumab
The drug Avelumab
The drug Atezolizumab
The drug Ipilimumab
